RNA-based technologies are a powerful molecular biology toolbox, empowering scientists to decipher the complexities of living ...

“Newer RNA interference therapeutics, patisiran and vutrisiran, show significant promise as an effective treatment for transthyretin amyloid cardiomyopathy (ATTR-CM),” Farhan Naeem ...

Background Fibrolamellar carcinoma (FLC), a rare and fatal liver cancer lacking effective drug therapy, is driven by the DNAJ ...

RNAi (RNA interference) is a biological process in which RNA molecules—microRNA (miRNA) and small interfering RNA (siRNA)—inhibit gene expression, typically by binding to messenger RNA (mRNA ...

The yeast RGG motif-containing RNA binding protein Scd6 and its human ortholog LSM14A regulate the translation of specific ...

A new study reveals that stress during pregnancy can molecularly reprogram newborns' stress response systems, with significant differences between boys and girls.

The FDA has approved the first ever RNA interference drug – Alnylam’s Onpattro (patisiran) for the nerve damage caused by the rare disease hereditary transthyretin-mediated amyloidosis (hATTR ...

who have also signed separate partnerships to develop new therapies for neurological diseases using RNA interference (RNAi) technology. While there are RNAi products on the marketplace ...

Cutting-edge DNA mapping technology identified new genetic information that can help researchers decipher more genetic diseases, a new study found.

The international community has a golden opportunity to start reining in the escalating, mostly ignored global burden of chronic kidney disease.

McLaren's Oscar Piastri took a controlled, dominant victory in the Bahrain Grand Prix to close on team-mate Lando Norris in the world championship. The Australian was serene in the lead, calmly ...